ALBANY, N.Y., Nov. 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer, President and Chief Executive Officer, is scheduled to present at the 2016 Canaccord Genuity Medical Technologies and Diagnostics Forum on November 17 at 4:30pm EST. The conference will be held at the Westin Grand Central Hotel in New York City.

A live audio and/or webcast and subsequent archived replay of AngioDynamics' presentation may be accessed via the investor relations section of the Company's website under "Events & Presentations" at http://investors.angiodynamics.com/events.cfm. The replay will be available for 90 days after the event.

About AngioDynamics AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.

TrademarksAngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.

Company Contact:AngioDynamics Inc.Caitlin Stefanik(518) 795-1418cstefanik@angiodynamics.com  Investor Relations Contacts:FTI ConsultingJim Polson(312) 553-6730Jim.Polson@fticonsulting.com,Kotaro Yoshida(212) 850-5690Kotaro.Yoshida@fticonsulting.com Media Contact:FTI ConsultingKimberly Ha(212) 850-5612kimberly.ha@fticonsulting.com 

Primary Logo